Márton Mohás

1.1k citations

21 papers · 890 indexed · 1 hit paper · h-index 11

Molecular Biology
Physiology top 10%
Geriatrics and Gerontology top 1%
Endocrinology, Diabetes and Metabolism top 10%
Epidemiology

Co-authors: István Wittmann Judit Cseh G Molnár Lajos Markó Boglárka Laczy István András Szijártó Esztella Mikolás Ákos Mérei
Topics: Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers)Advanced Glycation End Products research (4 papers)Renal Diseases and Glomerulopathies (3 papers)
Cited by: Geriatrics and Gerontology Biochemistry Physiology
Journals: Kidney International Life Sciences British Journal Of Nutrition
Partner nations: Hungary United Kingdom Poland

In The Last Decade

Márton Mohás

19 papers receiving 870 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

2011 546 citations Pál Brasnyó, G Molnár et al. British Journal Of Nutrition profile →

Peers

Countries citing papers authored by Márton Mohás

Since Specialization

Citations

This map shows the geographic impact of Márton Mohás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Márton Mohás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Márton Mohás more than expected).

Fields of papers citing papers by Márton Mohás

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Márton Mohás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Márton Mohás. The network helps show where Márton Mohás may publish in the future.

Co-authorship network of co-authors of Márton Mohás

This figure shows the co-authorship network connecting the top 25 collaborators of Márton Mohás. A scholar is included among the top collaborators of Márton Mohás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Márton Mohás. Márton Mohás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Similarities in Serum Acylcarnitine Patterns in Type 1 and Type 2 Diabetes Mellitus and in Metabolic Syndrome 2012 ·Annals of Nutrition and Metabolism ·Judit Bene,(unknown),Márton Mohás,(unknown),(unknown),Tamás Oroszlán,Beáta Gasztonyi,István Wittmann,Béla Melegh	50
2	Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patientsbreakdown → 2011 ·British Journal Of Nutrition ·Pál Brasnyó,G Molnár,Márton Mohás,Lajos Markó,Boglárka Laczy,Judit Cseh,Esztella Mikolás,István András Szijártó,Ákos Mérei,Richárd Halmai,László Mészáros,Balázs Sümegi,István Wittmann	546
3	Common functional variants of APOA5 and GCKR accumulate gradually in association with triglyceride increase in metabolic syndrome patients 2011 ·Molecular Biology Reports ·(unknown),Péter Kisfali,Márton Mohás,Anita Maász,(unknown),(unknown),István Wittmann,Béla Melegh	7
4	Stepwise Positive Association Between APOA5 Minor Allele Frequencies and Increasing Plasma Triglyceride Quartiles in Random Patients with Hypertriglyceridemia of Unclarified Origin 2010 ·Pathology & Oncology Research ·(unknown),Péter Kisfali,Márton Mohás,Anita Maász,Katalin Sümegi,Melinda Zsuzsanna Szabó,(unknown),(unknown),(unknown),István Wittmann,Béla Melegh	4
5	GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? 2010 ·Cardiovascular Diabetology ·Márton Mohás,Péter Kisfali,Luca Járomi,Anita Maász,(unknown),Veronika Csöngei,Noémi Polgár,Enikő Sáfrány,Judit Cseh,Katalin Sümegi,(unknown),István Wittmann,Béla Melegh	33
6	Microalbuminuria in inflammatory bowel diseases using immunoturbidimetry and high-performance liquid chromatography. 2010 ·PubMed ·(unknown),Lajos Markó,G Molnár,(unknown),Judit Cseh,Márton Mohás,Mária Figler,András Király,Tamás Kőszegi,István Wittmann	2
7	Evidence of O-linked N-acetylglucosamine in diabetic nephropathy 2009 ·Life Sciences ·Péter Degrell,Judit Cseh,Márton Mohás,G Molnár,László Pajor,John C. Chatham,Norbert Fülöp,István Wittmann	46
8	Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome 2009 ·Nutrition Metabolism and Cardiovascular Diseases ·Péter Kisfali,Márton Mohás,Anita Maász,Noémi Polgár,(unknown),Lajos Markó,Pál Brasnyó,Katalin Horvatovich,Tamás Oroszlán,(unknown),(unknown),Beáta Gasztonyi,(unknown),István Wittmann,Béla Melegh	32
9	Functional Variants of Glucokinase Regulatory Protein and Apolipoprotein A5 Genes in Ischemic Stroke 2009 ·Journal of Molecular Neuroscience ·Luca Járomi,Veronika Csöngei,Noémi Polgár,Zoltán Szolnoki,Anita Maász,Katalin Horvatovich,Bernadett Faragó,Csilla Sipeky,Enikő Sáfrány,Lili Magyari,Péter Kisfali,Márton Mohás,(unknown),Lilla Lakner,Béla Melegh	20
10	A Polymorphism within the Fructosamine-3-kinase Gene is Associated with HbA_1c Levels and the Onset of Type 2 Diabetes Mellitus 2009 ·Experimental and Clinical Endocrinology & Diabetes ·Márton Mohás,Péter Kisfali,(unknown),Ákos Mérei,Anita Maász,Judit Cseh,Esztella Mikolás,István András Szijártó,Béla Melegh,István Wittmann	24
11	Apolipoprotein A5 gene APOA52 haplotype variant confers risk for the development of metabolic syndrome 2008 ·Repository of the Academy's Library (Library of the Hungarian Academy of Sciences)* ·Péter Kisfali,Márton Mohás,Anita Maász,(unknown),Lajos Markó,(unknown),Tamás Oroszlán,(unknown),(unknown),(unknown),(unknown),István Wittmann,Béla Melegh	0
12	Morphology of Glomerular Hematuria Is Reproduced in vitro by Carbonyl Stress 2008 ·Nephron Experimental Nephrology ·Péter Degrell,Zoltán Wagner,István András Szijártó,László Wagner,Lajos Markó,Márton Mohás,(unknown),István Wittmann	2
13	Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus 2008 ·Acta Diabetologica ·Boglárka Laczy,Judit Cseh,Márton Mohás,Lajos Markó,(unknown),Tamás Kőszegi,G Molnár,Zoltán Wagner,László Wagner,István Wittmann	14
14	Serum Total LDH Activity and LDH-2 Isozyme in Nephrotic Syndrome 2008 ·Kidney & Blood Pressure Research ·Márton Mohás,(unknown),Lajos Markó,G Molnár,Judit Cseh,Boglárka Laczy,(unknown),József Balla,János Kappelmayer,László Wagner,Zoltán Wagner,Botond Csiky,Judit Nagy,István Wittmann	0
15	[The pleiotropic effects of losartan--the importance of decreasing uric acid level]. 2008 ·PubMed ·Botond Csiky,Lajos Markó,Márton Mohás,(unknown),Esztella Mikolás,István András Szijártó,István Wittmann	2
16	Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis 2007 ·Acta Physiologica Hungarica ·István Wittmann,G Molnár,László Wagner,Tamás Kőszegi,Zoltán Wagner,Boglárka Laczy,(unknown),Lajos Markó,Márton Mohás,Judit Nagy	2
17	Cigarette Smoke-Induced Alterations in Endothelial Nitric Oxide Synthase Phosphorylation: Role of Protein Kinase C 2007 ·Endothelium ·László Wagner,Boglárka Laczy,(unknown),István Mazák,Lajos Markó,G Molnár,Zoltán Wagner,Márton Mohás,Judit Cseh,Andrea Fekete,István Wittmann	30
18	Analysis of microalbuminuria with immunonephelometry and high performance liquid chromatography. Evaluation of new criteria 2007 ·Orvosi Hetilap ·Lajos Markó,G Molnár,Zoltán Wagner,Tamás Kőszegi,Zoltán Matus,Márton Mohás,Mónika Kuzma,István András Szijártó,István Wittmann	5
19	Importance of hereditary haemochromatosis in the care of diabetes mellitus 2007 ·Orvosi Hetilap ·István Wittmann,László Wagner,Lajos Markó,(unknown),Boglárka Laczy,Márton Mohás,Judit Cseh,Béla Melegh	2
20	Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: Evidence for hydroxyl radical production 2005 ·Kidney International ·G Molnár,Zoltán Wagner,Lajos Markó,Tamás Kőszegi,Márton Mohás,Béla Kocsis,Zoltán Matus,László Wagner,(unknown),István Mazák,Boglárka Laczy,Judit Nagy,István Wittmann	44

About Márton Mohás

Márton Mohás is a scholar working on Clinical Biochemistry, Nephrology and Endocrinology, Diabetes and Metabolism, having authored 21 papers that have together received 890 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Advanced Glycation End Products research (4 papers) and Renal Diseases and Glomerulopathies (3 papers). The work is most often cited by research in Geriatrics and Gerontology (292 citations), Biochemistry (76 citations) and Physiology (319 citations). Márton Mohás has collaborated with scholars based in Hungary, United Kingdom and Poland. Frequent co-authors include István Wittmann, Judit Cseh, G Molnár, Lajos Markó, Boglárka Laczy, István András Szijártó, Esztella Mikolás, Ákos Mérei, Pál Brasnyó and László Mészáros. Their work appears in journals such as Kidney International, Life Sciences and British Journal Of Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact